Relationship of Sarcopenia and Frailty in Patients With Outcomes in Idiopathic Pulmonary Fibrosis

被引：0
|
作者：
Sridhar, M. [1 ]
Bodduluri, S. [2 ]
O'Hare, L. [3 ]
Luckhardt, T. R. [4 ]
Mcdonald, M. N. [5 ]
Kulkarni, T. [5 ]
机构：
[1] Univ Alabama Birmingham, Pulm & Crit Care Med, Birmingham, AL USA
[2] Univ Alabama Birmingham, Pulm Allergy & Crit Care Med, Birmingham, AL USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] UAB, Dept Med, Birmingham, AL USA
[5] Univ Alabama Birmingham, Med, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2565
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical Outcomes In Patients With Idiopathic Pulmonary Fibrosis: Data From Comet
    Scott, J. P.
    Tayob, N.
    Han, M. K.
    Martinez, F. J.
    Murray, S.
    White, E. S.
    Flaherty, K. R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [32] Humoral Immune Status in Relation to Outcomes in Patients with Idiopathic Pulmonary Fibrosis
    Hoffman, T. W.
    van Moorsel, C. H. M.
    Kazemier, K. M.
    Biesma, D. H.
    Grutters, J. C.
    van Kessel, D. A.
    [J]. LUNG, 2021, 199 (06) : 667 - 676
  • [33] Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis
    Rangappa, Pradeep
    Moran, John L.
    [J]. CRITICAL CARE AND RESUSCITATION, 2009, 11 (02) : 102 - 109
  • [34] Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
    Belhassen, Manon
    Dalon, Faustine
    Nolin, Maeva
    Van Ganse, Eric
    [J]. RESPIRATORY RESEARCH, 2021, 22 (01)
  • [35] Post-Pharmacologic Treatment Outcomes For Patients With Idiopathic Pulmonary Fibrosis
    Weinstein, D. J.
    Ondrasik, N. R.
    Forbes, D. A.
    Morris, M. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [36] Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis
    Alhamad, Esam H.
    Masood, Mohamed
    Shaik, Shaffi Ahmad
    Arafah, Maha
    [J]. CLINICAL RESPIRATORY JOURNAL, 2008, 2 (04): : 220 - 226
  • [37] Idiopathic pulmonary fibrosis patients with severe physiologic impairment: characteristics and outcomes
    Jean Pastre
    Scott Barnett
    Inga Ksovreli
    Jeannie Taylor
    A. Whitney Brown
    Oksana A. Shlobin
    Kareem Ahmad
    Vikramjit Khangoora
    Shambhu Aryal
    Christopher S. King
    Steven D. Nathan
    [J]. Respiratory Research, 22
  • [38] Humoral Immune Status in Relation to Outcomes in Patients with Idiopathic Pulmonary Fibrosis
    T. W. Hoffman
    C. H. M. van Moorsel
    K. M. Kazemier
    D. H. Biesma
    J. C. Grutters
    D. A. van Kessel
    [J]. Lung, 2021, 199 : 667 - 676
  • [39] Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
    Kohei Fujita
    Hirotsugu Ohkubo
    Akiko Nakano
    Norihisa Takeda
    Kensuke Fukumitsu
    Satoshi Fukuda
    Yoshihiro Kanemitsu
    Takehiro Uemura
    Tomoko Tajiri
    Ken Maeno
    Yutaka Ito
    Tetsuya Oguri
    Yoshiyuki Ozawa
    Takayuki Murase
    Akio Niimi
    [J]. BMC Pulmonary Medicine, 22
  • [40] Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
    Fujita, Kohei
    Ohkubo, Hirotsugu
    Nakano, Akiko
    Takeda, Norihisa
    Fukumitsu, Kensuke
    Fukuda, Satoshi
    Kanemitsu, Yoshihiro
    Uemura, Takehiro
    Tajiri, Tomoko
    Maeno, Ken
    Ito, Yutaka
    Oguri, Tetsuya
    Ozawa, Yoshiyuki
    Murase, Takayuki
    Niimi, Akio
    [J]. BMC PULMONARY MEDICINE, 2022, 22 (01)
12345